Ignite Creation Date:
2024-07-17 @ 10:54 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06483100
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-25
Brief Title:
Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Organization Data
Organization:
Washington University School of Medicine
Class:
OTHER
Study ID:
24-x176
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Washington University School of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Comprehensive Cancer Network | NETWORK |
| Pfizer | INDUSTRY |
| Rapid Novor | UNKNOWN |